GUGGENHEIM CAPITAL LLC - AVANIR PHARMACEUTICALS INC ownership

AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 100 filers reported holding AVANIR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of AVANIR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$1,408,000
+2773.5%
83,079
+520.2%
0.00%
Q1 2014$49,000
-5.8%
13,395
-13.3%
0.00%
Q4 2013$52,000
-7.1%
15,457
+18.1%
0.00%
Q3 2013$56,000
-5.1%
13,090
+1.6%
0.00%
Q2 2013$59,00012,8850.00%
Other shareholders
AVANIR PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
JAY JEFFREY R 258,600$1,190,0000.94%
BVF INC/IL 1,006,053$4,628,0000.90%
Artal Group S.A. 2,750,000$12,650,0000.40%
Baker Brothers Advisors 3,578,591$16,462,0000.33%
EAM Investors, LLC 237,017$1,090,0000.24%
Opus Trading Fund LLC 23,888$110,0000.21%
FORTALEZA ASSET MANAGEMENT INC/ 61,795$284,0000.16%
CR Intrinsic Investors, LLC 898,538$4,133,0000.14%
TimesSquare Capital Management, LLC 4,261,478$19,603,0000.12%
Lyons Wealth Management, LLC. 25,340$116,0000.12%
View complete list of AVANIR PHARMACEUTICALS INC shareholders